Moleculin Biotech, Inc. Prepaid Expense, Current
Moleculin Biotech, Inc. (MBRX) had Prepaid Expense, Current of $2.75 million as of 2019-12-31, per its 10-K filed 2020-03-19.
Discontinued › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidExpenseCurrent · last filed 2020-03-19
- 2019-12-31: Prepaid Expense, Current $2.75M.
- 2019-06-30: Prepaid Expense, Current $1.51M.
- 2019-03-31: Prepaid Expense, Current $831.00K.
- 2018-12-31: Prepaid Expense, Current $840.00K.
| Period end | Prepaid Expense, Current | Prepaid Expense, Current as first filed |
|---|---|---|
| 2019-12-31 | $2.75M 10-K · filed 2020-03-19 | |
| 2019-06-30 | $1.51M 10-Q · filed 2019-08-16 | |
| 2019-03-31 | $831.00K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $840.00K 10-K · filed 2020-03-19 | |
| 2017-12-31 | $588.00K 10-K · filed 2019-02-21 | |
| 2017-06-30 | $809.00K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $269.00K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $215.00K 10-K · filed 2018-03-28 | $215.05K 10-K · filed 2017-04-03 |
| 2016-09-30 | $244.87K 10-Q · filed 2016-11-21 | |
| 2016-06-30 | $315.14K 10-Q · filed 2016-11-21 | |
| 2015-12-31 | $0.00 10-K · filed 2017-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |